<DOC>
	<DOCNO>NCT02843295</DOCNO>
	<brief_summary>Chronic Allograft Nephropathy ( CAN ) , major cause late allograft failure , characterize progressive decline graft function correlate tissue destruction . Recent data suggest may possible delay graft destruction adequate management initiate early ( ie , stage subclinical CAN ) . It therefore essential design new test allow physician predict transplant recipient prone develop CAN</brief_summary>
	<brief_title>Catalytic Antibodies Predict Uninvasively Late Transplant Failure</brief_title>
	<detailed_description>Superantibodies multifunctional antibody combine classical antigen-binding function nonclassical biological activity , protease-like activity . In past year role proteolytic SuperAntibody ( pSAb ) evidence many biological process role may either deleterious ( autoimmune disease , alloimmune response ) beneficial ( sepsis ) . Nothing know far regard role pSAb set solid organ transplantation . Preliminary data The investigator obtain preliminary result retrospective case control study indicate elevate serine protease activity circulate IgG ( measure hydrolysis synthetic fluorescent substrate : Proline-Phenylalanine-Arginine-Methylcoumarinamide ( PFR-MCA ) ) , correlate absence CAN protocol biopsy perform 2 year post-transplantation . Interestingly , low level proteolysis IgG , measure 3 month post-transplantation , also predictive CAN 2 year lane . Aim Research project : The aim validate prospective study , potential pSAb predictive marker CAN 100 recipient renal graft enrol follow 2 year . The level PFR-MCA hydrolysis circulate Immunoglobulin G ( IgG ) measure transplantation every 3 month one year every 6 month thereafter 2 year post-transplantation . The development CAN assess estimate glomerular filtration rate ( Modification Diet Renal Disease ( MDRD ) formula ) , proteinuria histological examination graft ( screen biopsy 3 month 1 year analyse use computerized color image analysis quantify interstitial fibrosis ) . The capacity pSAb test predict CAN validate sensibility specificity test calculate . The optimal cut-off value determine Receiver Operating Characteristic ( ROC ) analysis . The accuracy test evaluate subgroup display various risk factor CAN .</detailed_description>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Age &gt; 18 day transplantation Recipient renal graft Informed consent participate study Patient transplant follow 2 year one 3 transplantation center study ( Hospital Edouard Herriot Centre Hospitalier Lyon Sud ) Multiorgan transplantation Previous transplantation ABO incompatible renal transplantation Patient &gt; 18 year old guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>renal transplantation</keyword>
	<keyword>immunology</keyword>
	<keyword>rejection</keyword>
</DOC>